Most Read Articles
one year ago
Entecavir yields more favourable survival outcomes than lamivudine treatment in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), as shown in a retrospective cohort study.
one year ago
Saccharomyces boulardii has favourable safety and efficacy in the treatment of children aged 3 months to 5 years with acute rotavirus diarrhoea, based on a double-blind, randomised controlled trial from a developing country.
one year ago
Hepatitis C virus (HCV) infection is linked with increased risk of chronic kidney disease (CKD) in adults as shown in a systematic review and meta-analysis of 23 studies.
Pearl Toh, one month ago
Celecoxib is preferred over naproxen when added to proton-pump inhibitor (PPI) for preventing recurrent upper gastrointestinal (GI) bleeding in patients at high risk of both GI and cardiovascular (CV) events, who require concomitant aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), according to the CONCERN* study.

Adjunct boceprevir effective for patients with HIV/HCV-genotype-1 coinfection unresponsive to PEGIFN/RBV

one year ago
Adjunct boceprevir treatment is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study. An overall sustained virological response rate of 89 percent was reached in the intention to treat analysis.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
one year ago
Entecavir yields more favourable survival outcomes than lamivudine treatment in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), as shown in a retrospective cohort study.
one year ago
Saccharomyces boulardii has favourable safety and efficacy in the treatment of children aged 3 months to 5 years with acute rotavirus diarrhoea, based on a double-blind, randomised controlled trial from a developing country.
one year ago
Hepatitis C virus (HCV) infection is linked with increased risk of chronic kidney disease (CKD) in adults as shown in a systematic review and meta-analysis of 23 studies.
Pearl Toh, one month ago
Celecoxib is preferred over naproxen when added to proton-pump inhibitor (PPI) for preventing recurrent upper gastrointestinal (GI) bleeding in patients at high risk of both GI and cardiovascular (CV) events, who require concomitant aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), according to the CONCERN* study.